产品封面图

S49.1

收藏
  • 询价
  • 2026年03月01日
    avatar
    15金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 品系

      BALB/c

    • 物种来源

      小鼠

    • 是否是肿瘤细胞

      0

    • 细胞类型

      T淋巴细胞

    • 生长状态

      悬浮生长

    • 相关疾病

      淋巴瘤

    • ATCC Number

      TIB-28™

    • 细胞形态

      淋巴样

    • 运输方式

      冻存运输

    • 库存

      大量

    Designations: S49.1
    Depositors:  AW Harris
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: suspension
    Organism: Mus musculus
    Morphology: lymphoblast

    Source: Disease: lymphoma
    Strain: BALB/c
    Cell Type: T lymphocyte;
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Antigen Expression: H-2d; Thy-1.2; TL
    Cytogenetic Analysis: diploid
    Comments: The cells are sensitive to 0.001 mM cortisol.
    5mcg/ml phytohemagglutinin and 0.01 mM 6-thioguanine.
    Tested and found negative for ectromelia virus (mousepox).
    Propagation: ATCC complete growth medium: Dulbecco's modified Eagle's medium, 90%; horse serum, 10%
    Subculturing: Medium Renewal: Every 2 to 3 days
    Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
    References: 1104: Ralph P. Retention of lymphocyte characteristics by myelomas and theta+-lymphomas: sensitivity to cortisol and phytohemagglutinin. J. Immunol. 110: 1470-1475, 1973. PubMed: 4541304
    1129: Hyman R. Studies on surface antigen variants. Isolation of two complementary variants for Thy 1.2. J. Natl. Cancer Inst. 50: 415-422, 1973. PubMed: 4702114
    1130: Ralph P, et al. Independence of theta and TL surface antigens and killing by thymidine, cortisol, phytohemagglutinin, and cyclic AMP in a murine lymphoma. Biochem. Biophys. Res. Commun. 55: 1085-1091, 1973. PubMed: 4358928
    1131: Harris AW. Differentiated functions expressed by cultured mouse lymphoma cells. I. Specificity and kinetics of cell responses to corticosteroids. Exp. Cell Res. 60: 341-353, 1970. PubMed: 5422965
    22154: Horibata K, Harris AW. Mouse myelomas and lymphomas in culture. Exp. Cell Res. 60: 61-77, 1970. PubMed: 5439579
    22177: Bourgeois S, Newby RF. Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines. Cell 11: 423-460, 1977. PubMed: 560913
    22241: Schiller JG, et al. Glucocorticoid receptors in lymphoma cells in culture: relationship to glucocorticoid killing activity. Science 171: 189-191, 1971. PubMed: 4395230
    22528: Ralph P, Nakoinz I. Inhibitory effects of lectins and lymphocyte mitogens on murine lymphomas and myelomas. J. Natl. Cancer Inst. 51: 883-890, 1973. PubMed: 4542714

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • MECP2复制与男性的智力障碍

      MECP2的突变可以导致持续性神经系统退化(neurodegenerative disorder)Rett综合症。这个x-染色体相关综合症(X-linked syndrome)主要在女性身上体现,但相对温和的突变也可以导致男性的智力障碍(mental retardation)。 (Figure 1: Pedigrees of the four families (L36, S49, T33, and T

    • 抗体对细胞的毒性剂量 Toxic dose of antibiotics for cell lines

      Namalwa 500 1500   Xeno AE3 200     S49 1000     S49 kin- 500    

    • 侵袭性曲霉菌病---血液肿瘤之常见并发症

      of a prospective multicenter surveillance program [J]. Med Myeol, 2005,43 suppl 1:S49-S58 3. 徐明珠,孙爱宁,吴德沛,,血清半乳甘露聚糖抗原检测对血液病患者侵袭性肺曲霉病的诊断及预后价值,中国抗感染化疗杂志2009年5月20日第9卷第3期 4. 中华内科杂志编辑委员会,血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(修订版)[J].中华内科杂志,2007,46(7):607-610

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    ATCC细胞库
    2026年03月01日询价
    ¥1200
    上海晅科生物科技有限公司
    2025年07月10日询价
    询价
    北京中源合聚生物科技有限公司
    2026年01月22日询价
    ¥1400
    上海盖宁生物科技有限公司
    2026年01月27日询价
    S49.1
    询价